Laboratory Aktie

Laboratory für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 895308 / ISIN: US50540R4092

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
11.02.2021 13:20:15

Labcorp Issues Outlook - Quick Facts

(RTTNews) - Labcorp (LH) said, for 2021, the company expects: adjusted EPS in a range of $19.00 to $23.00; and total Labcorp Enterprise revenue in a range of a decline of 1.0% to an increase of 4.5%; and free cash flow of $1.7 billion to $1.9 billion.

Fourth quarter adjusted EPS were $10.56, up from $2.86, last year. Revenue for the quarter was $4.49 billion, an increase of 52.0% over $2.95 billion, a year ago. The increase in revenue was due to organic growth of 50.1%. This increase in organic revenue includes a 46.4% contribution from COVID-19 Testing and a 3.7% increase in the company's organic Base Business.

Shares of Labcorp were up nearly 5% in pre-market trade on Thursday.

Analysen zu Laboratory Corp. of America Holdingsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!